Esther Rajavelu

Companies

• Spero Therapeutics, Inc.Chief financial officer Nov 12, 2024 to now¹
• Spero Therapeutics, Inc.Officer Nov 15, 2023 to now²
• Fulcrum Therapeutics (United States)Chief financial officer Jan 10, 2022 to Feb 13, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STSpero Therapeutics, Inc. SPRO986,851 shares⁴$1.1M at $1.11May 4, 2026
• FTFulcrum Therapeutics (United States) FULC0 shares⁵Jan 10, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• May 4, 2026Sold 25,240 shares at $2.51 of Spero Therapeutics, Inc.⁴
• Feb 6, 2026Sold 50,816 shares at $2.36 of Spero Therapeutics, Inc.⁶
• Feb 6, 2026Sold 37,101 shares at $2.36 of Spero Therapeutics, Inc.⁶
• Feb 2, 2026Sold 18,442 shares at $2.20 of Spero Therapeutics, Inc.⁷
• Feb 2, 2026Granted 249,000 shares of Spero Therapeutics, Inc.⁷
• Nov 7, 2025Sold 40,270 shares at $2.37 of Spero Therapeutics, Inc.⁸
• May 2, 2025Granted 185,000 shares of Spero Therapeutics, Inc.⁹
• Feb 5, 2025Sold 20,689 shares at $0.78 of Spero Therapeutics, Inc.¹⁰
• Feb 3, 2025Granted 100,000 shares of Spero Therapeutics, Inc.¹⁰
• Feb 3, 2025Granted 266,139 shares of Spero Therapeutics, Inc.¹⁰
• Nov 8, 2024Sold 17,245 shares at $1.30 of Spero Therapeutics, Inc.¹¹
• Nov 7, 2024Sold 23,351 shares at $1.31 of Spero Therapeutics, Inc.¹¹
• Feb 1, 2024Granted 119,866 shares of Spero Therapeutics, Inc.¹²
• Nov 13, 2023Granted 300,000 shares of Spero Therapeutics, Inc.¹³